Golden State Equity Partners Makes New $387,000 Investment in Danaher Corporation $DHR

Key Points

• Golden State Equity Partners made a new investment in Danaher Corporation, acquiring 1,957 shares worth approximately $387,000 during the second quarter.
• Danaher reported earnings of $1.80 per share for the quarter, exceeding analysts' estimates, with a revenue of $5.94 billion—a 3.4% increase year-over-year.
• The company has announced a quarterly dividend of $0.32 per share, representing an annualized yield of 0.7%, payable on October 31st to shareholders on record as of September 26th.

Golden State Equity Partners acquired a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,957 shares of the conglomerate's stock, valued at approximately $387,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. GHP Investment Advisors Inc. raised its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares during the period. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the fourth quarter valued at $27,000. Sierra Ocean LLC raised its position in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher in the first quarter valued at about $31,000. Finally, Dunhill Financial LLC lifted its stake in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Guggenheim reissued a "buy" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Barclays reiterated an "overweight" rating and set a $225.00 target price (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. UBS Group dropped their price target on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Finally, Wells Fargo & Company lowered their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $245.91.

Danaher Price Performance

Danaher stock opened at $189.24 on Wednesday. The firm has a market cap of $135.50 billion, a PE ratio of 40.26, a price-to-earnings-growth ratio of 2.66 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The stock's fifty day moving average price is $199.95 and its two-hundred day moving average price is $197.97. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the prior year, the company posted $1.72 EPS. The company's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's dividend payout ratio (DPR) is currently 27.23%.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 11.20% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.